HDAC8 and hepatocellular carcinoma: PCI‐34051, an inhibitor of HDAC8, has been shown to have antitumor effects in previous studies.[27] HDAC8 is a key downstream protein of PA that promotes HCC progression; therefore, we verified whether PCI‐34051 is suitable for the treatment of HCC caused by a high‐PA diet.